Three Scientists Win 2026 Nobel for Optogenetics — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Karl Deisseroth, Peter Hegemann, and Georg Nagel won the 2026 Nobel Prize in Physiology or Medicine for their work on "light-gated ion channels and optogenetics," announced October 19, 2026.
- Hegemann (Humboldt University of Berlin) and Nagel (University of Würzburg) discovered channelrhodopsin in Chlamydomonas, a single-celled alga that uses the light-sensitive protein to swim toward light by opening ion channels when retinaldehyde absorbs photons.
- Deisseroth (Stanford), Hegemann, and Nagel developed optogenetics by inserting channelrhodopsin into nerve cells, allowing scientists to switch specific neurons on and off by shining light through a thin optical fiber while leaving nearby cells unaffected.
- In a 2012 MIT experiment in which Deisseroth was a co-author, mice froze in fear when light reactivated nerve cells tagged during an earlier electric shock — proving optogenetics can reactivate a specific memory on demand.
- Optogenetics is already in early-stage clinical trials to restore vision in people with retinal degeneration by making surviving retinal cells light-responsive, and researchers are investigating its use against Parkinson's and epilepsy.
- The Nobel recognizes a basic-science question — how does an alga swim toward light? — that the article notes "has no obvious practical importance" yet produced one of neuroscience's most powerful tools.
Why it matters: Optogenetics gives researchers precise, instant on/off control over specific nerve cells — a level of specificity no earlier neuroscience tool offered — and the first human trials are now underway for restoring vision in people with retinal degeneration, with Parkinson's and epilepsy under active investigation. The award explicitly honors curiosity-driven basic research as the seed of a clinical breakthrough.
Ask SkimNews
